China
Africa
Explore chapters and articles related to this topic
Vaginal or Vulvovaginal Atrophy/Atrophic Vaginitis/Genitourinary Syndrome of Menopause (GSM)
Published in Charles Theisler, Adjuvant Medical Care, 2023
Vaginal symptoms associated with menopause are common, affecting 40%–60% of postmenopausal women.1 Vulvovaginal atrophy, or atrophic vaginitis, is thinning and inflammation of the vaginal walls leading to a loss of elasticity. This leads to symptoms of uncomfortable or painful intercourse (dyspareunia), localized dryness, burning, pruritus, dysuria, and urinary incontinence. Loss of libido is also possible.
Sexual Health
Published in Carolyn Torkelson, Catherine Marienau, Beyond Menopause, 2023
Carolyn Torkelson, Catherine Marienau
Orgasms are likely to improve once the vagina, vulva, and urethra are healthy with adequate lubrication or with the use of estrogen. With the addition of a good vibrator and a willing partner, you will likely find orgasms come easier. If low libido continues to be a problem, then considering testosterone may be an option.
Dementia
Published in Henry J. Woodford, Essential Geriatrics, 2022
Cognitive impairment can affect sexual relationships. Memory, planning and judgement are all necessary components of intimacy. Libido may become reduced or increased. People with dementia may become less sensitive to their partner's needs. Disinhibition may develop. They could be demanding or aggressive in their requests for sexual interaction or be inappropriate around care staff. In addition, the capacity to consent to sex can become impaired, creating a risk of being the victim of abuse.
The Effects of Hormonal and Non-Hormonal Intrauterine Devices on Female Sexual Function: A Systematic Review
Published in International Journal of Sexual Health, 2023
Katherine Ogle, Ariel B. Handy
On the other hand, Herzberg et al. (1971) found a continuous increase in mean libido scores among the IUD group, with only a small change and no sign of continuous improvement for the OCP group over the course of eleven months. It is important to note that libido was assessed as a composition of sexual satisfaction, interest, and frequency of intercourse. In this study, no IUD was removed due to the loss of libido, however, 17 women stopped using OCPs for that reason. In addition, Oddens (1999) found that past IUD users reported decreased desire more often than current IUD users. Research has also demonstrated greater levels of desire among Cu-IUD users (Hassanin et al., 2018; Malmborg et al., 2016) and LNG-IUD users (Caruso et al., 2018; Skrzypulec & Drosdzol, 2008) when compared to users of other contraceptive methods. To a similar effect, LNG-IUD users reported an overall improvement in sexual desire from 0- to 12-months post-insertion (Bastianelli et al., 2011). Baldaszti et al. (2003) found that among 165 LNG-IUD users, 16 women removed their IUD prematurely, two of whom did so due to reduced libido.
Understanding and managing autonomic dysfunction in persons with multiple sclerosis
Published in Expert Review of Neurotherapeutics, 2021
Ivan Adamec, Magdalena Krbot Skorić, Mario Habek
Sexual dysfunction (SD) is reported to be present in more than 80% of pwMS [42]. It can be primary, due to decreased sensitivity in the genital area or decreased ability to orgasm or secondary due to fatigue, mobility problems, muscle weakness, or stiffness [44]. SD is often overlooked or underestimated as a symptom by neurologists and efforts should be made to reassure pwMS to talk freely about this subject. The etiology of SD in pwMS is thought to be a result of disruption of the hypothalamic–pituitary–gonadal axis due to demyelinating lesions [45]. As well, an association between the presence of sphinteric disorders and some symptoms of SD seems to exist [46,47]. Sexual hypoactivitiy is reported by most of the pwMS with SD [48]. Reduced libido is reported by both sexes, with men often experiencing erectile dysfunction and premature ejaculation and women decreased vaginal lubrication and difficulties in reaching orgasm [42]. All of this adds to pwMS less frequently having sexual intercourse compared to patients with other chronic diseases or healthy controls which adds to relationship dissatisfaction felt by pwMS and their partners [45,47]. Also, there is an association between cognitive deficits and sexuality disorders as pwMS with SD more often report problems with memory and concentration [46].
Attitude towards sexuality and sexual behaviors among men with heart rhythm disorders
Published in The Aging Male, 2020
Rafal Mlynarski, Agnieszka Mlynarska, Krzysztof S. Golba
Decreased sexual frequency and loss of libido can also predict a higher 10-year cardiovascular risk, what was documented by Ho et al in hypogonadal men [26]. The incidence of erectile dysfunction increases with age and depends on many health and psychosocial factors. The conditions and states that are associated with erectile dysfunction include diabetes, hypertension, coronary heart disease, obesity, difficult micturition, low socioeconomic status, sedentary lifestyle, smoking, depression, subjectively reported premature ejaculation, low libido, and irregular intercourse [27]. The lowest prevalence of erectile dysfunction is observed in men who do not have chronic conditions and live a healthy lifestyle. Erectile dysfunction can be seen as both a risk factor and a clinical manifestation of the progression of atherosclerosis [28]. We also believe that substances like Testofen, a specialized Trigonella foenum-graecum seed extract can support sexual function in aging males [29]. Rao et al. in a double-blind, randomized, placebo-controlled trial examined influence of Trigonella foenum-graecum seed in 120 healthy men aged between 43 and 70 years of age. Authors concluded that Testofen is a safe and effective treatment for reducing symptoms of possible androgen deficiency, improves sexual function and increases serum testosterone in healthy middle-aged and older men. Unfortunately, additional research in patients with cardiac arrythmias is necessary to support our thesis.